California Takes Action to Produce Affordable Insulin and Naloxone
TL;DR Summary
California will cap insulin costs at $30, a 90% reduction, through a collaboration between CalRx and non-profit drug manufacturer Civica Rx pending FDA approval. The state will also start manufacturing naloxone, a nasal spray used to reverse opioid overdoses, as part of its "Master Plan for Tackling the Fentanyl and Opioid Crisis." California is searching for a California-based naloxone manufacturing facility.
- California moves to cap insulin cost at $30, start manufacturing naloxone CNN
- California, drugmaker partner to produce affordable insulin The Independent
- California will produce its own $30 insulin. Next up: a drug to reverse fentanyl overdoses Sacramento Bee
- Newsom announces $50-million contract to make California's own brand of insulin Los Angeles Times
- California finally has a contract to make its own insulin. Next up: naloxone San Francisco Chronicle
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
2 min
vs 3 min read
Condensed
85%
420 → 61 words
Want the full story? Read the original article
Read on CNN